Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.
Leboulleux S, Bournaud C, Chougnet CN, Zerdoud S, Al Ghuzlan A, Catargi B, Do Cao C, Kelly A, Barge ML, Lacroix L, Dygai I, Vera P, Rusu D, Schneegans O, Benisvy D, Klein M, Roux J, Eberle MC, Bastie D, Nascimento C, Giraudet AL, Le Moullec N, Bardet S, Drui D, Roudaut N, Godbert Y, Morel O, Drutel A, Lamartina L, Schvartz C, Velayoudom FL, Schlumberger MJ, Leenhardt L, Borget I.
N Engl J Med. 2022 Mar 10;386(10):923-932. doi: 10.1056/NEJMoa2111953.
Hybrid Protein Nano-Reactors Enable Simultaneous Increments of Tumor Oxygenation and Iodine-131 Delivery for Enhanced Radionuclide Therapy.
Chen J, Liang C, Song X, Yi X, Yang K, Feng L, Liu Z.
Small. 2019 Nov;15(46):e1903628. doi: 10.1002/smll.201903628. Epub 2019 Oct 2.
Phase I study of [(131)I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol.
Thivat E, Rouanet J, Auzeloux P, Sas N, Jouberton E, Levesque S, Billoux T, Mansard S, Molnar I, Chanchou M, Fois G, Maigne L, Chezal JM, Miot-Noirault E, D'Incan M, Durando X, Cachin F.
BMC Cancer. 2022 Apr 15;22(1):417. doi: 10.1186/s12885-022-09495-3.
Lipid-Peptide-mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer.
Li Q, Zhang L, Lang J, Tan Z, Feng Q, Zhu F, Liu G, Ying Z, Yu X, Feng H, Yi H, Wen Q, Jin T, Cheng K, Zhao X, Ge M.
Adv Sci (Weinh). 2023 Jan;10(3):e2204334. doi: 10.1002/advs.202204334. Epub 2022 Dec 1.
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α.
Dekempeneer Y, Massa S, Santens F, Navarro L, Berdal M, Lucero MM, Pombo Antunes AR, Lahoutte T, Van Ginderachter JA, Devoogdt N, D'Huyvetter M.
J Nucl Med. 2023 Dec;64(12):1941-1948. doi: 10.2967/jnumed.123.266381.
Correlation analysis between the quantitative parameters of iodine-131 single-photon emission computed tomography-computed tomography thyroid bed uptake and the efficacy of radioactive iodine adjuvant therapy for papillary thyroid cancer.
Mao Y, Lin R, Wang Y, Yu J.
Quant Imaging Med Surg. 2024 May 1;14(5):3665-3675. doi: 10.21037/qims-23-1723. Epub 2024 Apr 26.
Smart (131) I-Labeled Self-Illuminating Photosensitizers for Deep Tumor Therapy.
Guo J, Feng K, Wu W, Ruan Y, Liu H, Han X, Shao G, Sun X.
Angew Chem Int Ed Engl. 2021 Sep 27;60(40):21884-21889. doi: 10.1002/anie.202107231. Epub 2021 Aug 26.
Aminosilanized flower-structured superparamagnetic iron oxide nanoparticles coupled to (131)I-labeled CC49 antibody for combined radionuclide and hyperthermia therapy of cancer.
Stanković A, Mihailović J, Mirković M, Radović M, Milanović Z, Ognjanović M, Janković D, Antić B, Mijović M, Vranješ-Đurić S, Prijović Ž.
Int J Pharm. 2020 Sep 25;587:119628. doi: 10.1016/j.ijpharm.2020.119628. Epub 2020 Jul 15.
Radiation dosimetry of [(131) I]ICF01012 in rabbits: Application to targeted radionuclide therapy for human melanoma treatment.
Jouberton E, Perrot Y, Dirat B, Billoux T, Auzeloux P, Cachin F, Chezal JM, Filaire M, Labarre P, Miot-Noirault E, Millardet C, Valla C, Vidal A, Degoul F, Maigne L.
Med Phys. 2018 Nov;45(11):5251-5262. doi: 10.1002/mp.13165. Epub 2018 Sep 24.
Highly Tumor-Specific and Long-Acting Iodine-131 Microbeads for Enhanced Treatment of Hepatocellular Carcinoma with Low-Dose Radio-Chemoembolization.
Qian Y, Liu Q, Li P, Han Y, Zhang J, Xu J, Sun J, Wu A, Song S, Lu W.
ACS Nano. 2021 Feb 23;15(2):2933-2946. doi: 10.1021/acsnano.0c09122. Epub 2021 Feb 2.
